{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:02:10Z","timestamp":1794024130859,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93019C00051"],"award-info":[{"award-number":["75N93019C00051"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI128821"],"award-info":[{"award-number":["AI128821"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI109946"],"award-info":[{"award-number":["AI109946"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI097092"],"award-info":[{"award-number":["AI097092"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN26620070010C"],"award-info":[{"award-number":["HHSN26620070010C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI109946"],"award-info":[{"award-number":["AI109946"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN26620070010C"],"award-info":[{"award-number":["HHSN26620070010C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400008C"],"award-info":[{"award-number":["HHSN272201400008C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI109946"],"award-info":[{"award-number":["AI109946"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1084518"],"award-info":[{"award-number":["OPP1084518"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1038\/s41591-020-1118-7","type":"journal-article","created":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T13:13:14Z","timestamp":1607346794000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":364,"title":["A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5568-5420","authenticated-orcid":false,"given":"Raffael","family":"Nachbagauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodi","family":"Feser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdollah","family":"Naficy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David I.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Guptill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel B.","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franceso","family":"Berlanda-Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6792-7650","authenticated-orcid":false,"given":"Daniel","family":"Stadlbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3537-1245","authenticated-orcid":false,"given":"Patrick C.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Aydillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Behzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1564-3298","authenticated-orcid":false,"given":"Disha","family":"Bhavsar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carly","family":"Bliss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Manuel","family":"Carre\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Chromikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Claeys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9880-6560","authenticated-orcid":false,"given":"Lynda","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5963-8995","authenticated-orcid":false,"given":"Alec W.","family":"Freyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Gast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Javier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaijun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mariottini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meagan","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"McNeal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirin","family":"Strohmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Van der Wielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L.","family":"Innis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6551-1827","authenticated-orcid":false,"given":"Adolfo","family":"Garc\u00eda-Sastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0337-5823","authenticated-orcid":false,"given":"Peter","family":"Palese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4121-776X","authenticated-orcid":false,"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,7]]},"reference":[{"key":"1118_CR1","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1038\/nm1141","volume":"10","author":"P Palese","year":"2004","unstructured":"Palese, P. Influenza: old and new threats. Nat. Med. 10, S82\u2013S87 (2004).","journal-title":"Nat. Med."},{"key":"1118_CR2","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.3201\/eid2410.180652","volume":"24","author":"MCW Chan","year":"2018","unstructured":"Chan, M. C. W. et al. Frequent genetic mismatch between vaccine strains and circulating seasonal influenza viruses, Hong Kong, China, 1996\u20132012. Emerg. Infect. Dis. 24, 1825\u20131834 (2018).","journal-title":"Emerg. Infect. Dis."},{"key":"1118_CR3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/infdis\/jiz543","volume":"221","author":"B Flannery","year":"2020","unstructured":"Flannery, B. et al. Spread of antigenically drifted influenza A(H3N2) viruses and vaccine effectiveness in the United States during the 2018\u20132019 season. J. Infect. Dis. 221, 8\u201315 (2020).","journal-title":"J. Infect. Dis."},{"key":"1118_CR4","first-page":"1900585","volume":"24","author":"DM Skowronski","year":"2019","unstructured":"Skowronski, D. M. et al. Paradoxical clade- and age-specific vaccine effectiveness during the 2018\/19 influenza A(H3N2) epidemic in Canada: potential imprint-regulated effect of vaccine (I-REV). Euro Surveill. 24, 1900585 (2019).","journal-title":"Euro Surveill."},{"key":"1118_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.15585\/mmwr.mm6902e1","volume":"69","author":"D Owusu","year":"2020","unstructured":"Owusu, D. et al. Early season pediatric influenza B\/Victoria virus infections associated with a recently emerged virus subclade\u2014Louisiana, 2019. MMWR Morb. Mortal. Wkly Rep. 69, 40\u201343 (2020).","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"1118_CR6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1073\/pnas.1916585116","volume":"117","author":"RK Virk","year":"2020","unstructured":"Virk, R. K. et al. Divergent evolutionary trajectories of influenza B viruses underlie their contemporaneous epidemic activity. Proc. Natl Acad. Sci. USA 117, 619\u2013628 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1118_CR7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd4529","volume":"14","author":"F Krammer","year":"2015","unstructured":"Krammer, F. & Palese, P. Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 14, 167\u2013182 (2015).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1118_CR8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"1118_CR9","first-page":"767","volume":"70","author":"D Hobson","year":"1972","unstructured":"Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg. (Lond.) 70, 767\u2013777 (1972).","journal-title":"J. Hyg. (Lond.)"},{"key":"1118_CR10","doi-asserted-by":"crossref","first-page":"20248","DOI":"10.1073\/pnas.1320524110","volume":"110","author":"NS Heaton","year":"2013","unstructured":"Heaton, N. S., Sachs, D., Chen, C. J., Hai, R. & Palese, P. Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins. Proc. Natl Acad. Sci. USA 110, 20248\u201320253 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1118_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3390\/v8060155","volume":"8","author":"MB Doud","year":"2016","unstructured":"Doud, M. B. & Bloom, J. D. Accurate measurement of the effects of all amino-acid mutations on influenza hemagglutinin. Viruses 8, 155 (2016).","journal-title":"Viruses"},{"key":"1118_CR12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28706-1","volume":"8","author":"E Kirkpatrick","year":"2018","unstructured":"Kirkpatrick, E., Qiu, X., Wilson, P. C., Bahl, J. & Krammer, F. The influenza virus hemagglutinin head evolves faster than the stalk domain. Sci. Rep. 8, 10432 (2018).","journal-title":"Sci. Rep."},{"key":"1118_CR13","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/jvi.67.5.2552-2558.1993","volume":"67","author":"Y Okuno","year":"1993","unstructured":"Okuno, Y., Isegawa, Y., Sasao, F. & Ueda, S. A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. J. Virol. 67, 2552\u20132558 (1993).","journal-title":"J. Virol."},{"key":"1118_CR14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41594-018-0025-9","volume":"25","author":"NC Wu","year":"2018","unstructured":"Wu, N. C. & Wilson, I. A. Structural insights into the design of novel anti-influenza therapies. Nat. Struct. Mol. Biol. 25, 115\u2013121 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1118_CR15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1205669","volume":"333","author":"D Corti","year":"2011","unstructured":"Corti, D. et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333, 850\u2013856 (2011).","journal-title":"Science"},{"key":"1118_CR16","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1126\/science.1222908","volume":"337","author":"C Dreyfus","year":"2012","unstructured":"Dreyfus, C. et al. Highly conserved protective epitopes on influenza B viruses. Science 337, 1343\u20131348 (2012).","journal-title":"Science"},{"key":"1118_CR17","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41591-019-0463-x","volume":"25","author":"S Ng","year":"2019","unstructured":"Ng, S. et al. Novel correlates of protection against pandemic H1N1 influenza A virus infection. Nat. Med. 25, 962\u2013967 (2019).","journal-title":"Nat. Med."},{"key":"1118_CR18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","volume":"20","author":"DJ Dilillo","year":"2014","unstructured":"Dilillo, D. J., Tan, G. S., Palese, P. & Ravetch, J. V. Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo. Nat. Med. 20, 143\u2013151 (2014).","journal-title":"Nat. Med."},{"key":"1118_CR19","doi-asserted-by":"crossref","first-page":"e80034","DOI":"10.1371\/journal.pone.0080034","volume":"8","author":"B Brandenburg","year":"2013","unstructured":"Brandenburg, B. et al. Mechanisms of hemagglutinin targeted influenza virus neutralization. PLoS ONE 8, e80034 (2013).","journal-title":"PLoS ONE"},{"key":"1118_CR20","doi-asserted-by":"crossref","first-page":"e02281","DOI":"10.1128\/mBio.02281-16","volume":"8","author":"M Rajendran","year":"2017","unstructured":"Rajendran, M. et al. Analysis of anti-influenza virus neuraminidase antibodies in children, adults, and the elderly by ELISA and enzyme inhibition: evidence for original antigenic Sin. mBio 8, e02281\u201316 (2017).","journal-title":"mBio"},{"key":"1118_CR21","doi-asserted-by":"crossref","first-page":"5774","DOI":"10.1128\/JVI.00137-12","volume":"86","author":"R Hai","year":"2012","unstructured":"Hai, R. et al. Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes. J. Virol. 86, 5774\u20135781 (2012).","journal-title":"J. Virol."},{"key":"1118_CR22","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","volume":"87","author":"I Margine","year":"2013","unstructured":"Margine, I. et al. Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses. J. Virol. 87, 10435\u201310446 (2013).","journal-title":"J. Virol."},{"key":"1118_CR23","doi-asserted-by":"crossref","first-page":"6542","DOI":"10.1128\/JVI.00641-13","volume":"87","author":"F Krammer","year":"2013","unstructured":"Krammer, F., Pica, N., Hai, R., Margine, I. & Palese, P. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J. Virol. 87, 6542\u20136550 (2013).","journal-title":"J. Virol."},{"key":"1118_CR24","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-017-0026-4","volume":"2","author":"R Nachbagauer","year":"2017","unstructured":"Nachbagauer, R. et al. A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies. NPJ Vaccines 2, 26 (2017).","journal-title":"NPJ Vaccines"},{"key":"1118_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4049\/immunohorizons.1900022","volume":"3","author":"A Choi","year":"2019","unstructured":"Choi, A. et al. Chimeric hemagglutinin-based influenza virus vaccines induce protective stalk-specific humoral immunity and cellular responses in mice. Immunohorizons 3, 133\u2013148 (2019).","journal-title":"Immunohorizons"},{"key":"1118_CR26","doi-asserted-by":"crossref","DOI":"10.1038\/npjvaccines.2016.15","volume":"1","author":"R Nachbagauer","year":"2016","unstructured":"Nachbagauer, R. et al. A chimeric haemagglutinin-based influenza split virion vaccine adjuvanted with AS03 induces protective stalk-reactive antibodies in mice. NPJ Vaccines 1, 16015 (2016).","journal-title":"NPJ Vaccines"},{"key":"1118_CR27","doi-asserted-by":"crossref","first-page":"e01996","DOI":"10.1128\/mBio.01996-15","volume":"7","author":"R Nachbagauer","year":"2016","unstructured":"Nachbagauer, R. et al. Age dependence and isotype specificity of influenza virus hemagglutinin stalk-reactive antibodies in humans. mBio 7, e01996\u201315 (2016).","journal-title":"mBio"},{"key":"1118_CR28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/cid\/cir121","volume":"52","author":"J Sui","year":"2011","unstructured":"Sui, J. et al. Wide prevalence of heterosubtypic broadly neutralizing human anti-influenza A antibodies. Clin. Infect. Dis. 52, 1003\u20131009 (2011).","journal-title":"Clin. Infect. Dis."},{"key":"1118_CR29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","volume":"20","author":"DI Bernstein","year":"2020","unstructured":"Bernstein, D. I. et al. Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial. Lancet Infect. Dis. 20, 80\u201391 (2020).","journal-title":"Lancet Infect. Dis."},{"key":"1118_CR30","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1093\/infdis\/jiu123","volume":"209","author":"KR Talaat","year":"2014","unstructured":"Talaat, K. R. et al. A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response. J. Infect. Dis. 209, 1860\u20131869 (2014).","journal-title":"J. Infect. Dis."},{"key":"1118_CR31","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1080\/21645515.2015.1069931","volume":"11","author":"L Rudenko","year":"2015","unstructured":"Rudenko, L. et al. Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine. Hum. Vaccin. Immunother. 11, 2839\u20132848 (2015).","journal-title":"Hum. Vaccin. Immunother."},{"key":"1118_CR32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/infdis\/jis641","volume":"207","author":"MI Barr\u00eda","year":"2013","unstructured":"Barr\u00eda, M. I. et al. Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J. Infect. Dis. 207, 115\u2013124 (2013).","journal-title":"J. Infect. Dis."},{"key":"1118_CR33","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/nm.4224","volume":"22","author":"J Lee","year":"2016","unstructured":"Lee, J. et al. Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination. Nat. Med. 22, 1456\u20131464 (2016).","journal-title":"Nat. Med."},{"key":"1118_CR34","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nature11414","volume":"489","author":"DC Ekiert","year":"2012","unstructured":"Ekiert, D. C. et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop. Nature 489, 526\u2013532 (2012).","journal-title":"Nature"},{"key":"1118_CR35","doi-asserted-by":"crossref","first-page":"85ra48","DOI":"10.1126\/scitranslmed.3002336","volume":"3","author":"S Khurana","year":"2011","unstructured":"Khurana, S. et al. MF59 adjuvant enhances diversity and affinity of antibody-mediated immune response to pandemic influenza vaccines. Sci. Transl. Med. 3, 85ra48 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1118_CR36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","volume":"324","author":"DC Ekiert","year":"2009","unstructured":"Ekiert, D. C. et al. Antibody recognition of a highly conserved influenza virus epitope. Science 324, 246\u2013251 (2009).","journal-title":"Science"},{"key":"1118_CR37","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","volume":"16","author":"J Sui","year":"2009","unstructured":"Sui, J. et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16, 265\u2013273 (2009).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"1118_CR38","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","volume":"88","author":"R Nachbagauer","year":"2014","unstructured":"Nachbagauer, R. et al. Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans. J. Virol. 88, 13260\u201313268 (2014).","journal-title":"J. Virol."},{"key":"1118_CR39","doi-asserted-by":"crossref","first-page":"13133","DOI":"10.1073\/pnas.1414070111","volume":"111","author":"AH Ellebedy","year":"2014","unstructured":"Ellebedy, A. H. et al. Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans. Proc. Natl Acad. Sci. USA 111, 13133\u201313138 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1118_CR40","doi-asserted-by":"crossref","first-page":"e01463","DOI":"10.1128\/mBio.01463-17","volume":"8","author":"H Jacobsen","year":"2017","unstructured":"Jacobsen, H. et al. Influenza virus hemagglutinin stalk-specific antibodies in human serum are a surrogate marker for in vivo protection in a serum transfer mouse challenge model. mBio 8, e01463\u201317 (2017).","journal-title":"mBio"},{"key":"1118_CR41","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2019.04.011","volume":"177","author":"S Bangaru","year":"2019","unstructured":"Bangaru, S. et al. A site of vulnerability on the influenza virus hemagglutinin head domain trimer interface. Cell 177, 1136\u20131152.e1118 (2019).","journal-title":"Cell"},{"key":"1118_CR42","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.cell.2019.03.048","volume":"177","author":"A Watanabe","year":"2019","unstructured":"Watanabe, A. et al. Antibodies to a conserved influenza head interface epitope protect by an IgG subtype-dependent mechanism. Cell 177, 1124\u20131135.e1116 (2019).","journal-title":"Cell"},{"key":"1118_CR43","doi-asserted-by":"crossref","DOI":"10.1038\/s41541-019-0147-z","volume":"4","author":"R Nachbagauer","year":"2019","unstructured":"Nachbagauer, R. et al. Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts. NPJ Vaccines 4, 51 (2019).","journal-title":"NPJ Vaccines"},{"key":"1118_CR44","volume":"8","author":"W He","year":"2017","unstructured":"He, W. et al. Alveolar macrophages are critical for broadly-reactive antibody-mediated protection against influenza A virus in mice. Nat. Commun. 8, 846 (2017).","journal-title":"Nat. Commun."},{"key":"1118_CR45","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.vaccine.2020.01.008","volume":"38","author":"V Chromikova","year":"2020","unstructured":"Chromikova, V. et al. Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay. Vaccine 38, 1953\u20131961 (2020).","journal-title":"Vaccine"},{"key":"1118_CR46","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.vaccine.2019.04.048","volume":"37","author":"C Cohet","year":"2019","unstructured":"Cohet, C. et al. Safety of AS03-adjuvanted influenza vaccines: a review of the evidence. Vaccine 37, 3006\u20133021 (2019).","journal-title":"Vaccine"},{"key":"1118_CR47","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1128\/JVI.03183-13","volume":"88","author":"F Krammer","year":"2014","unstructured":"Krammer, F. et al. H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge. J. Virol. 88, 2340\u20132343 (2014).","journal-title":"J. Virol."},{"key":"1118_CR48","first-page":"e00333","volume":"93","author":"W Sun","year":"2019","unstructured":"Sun, W. et al. Development of influenza B universal vaccine candidates using the \u2018mosaic\u2019 hemagglutinin approach. J. Virol. 93, e00333\u201319 (2019).","journal-title":"J. Virol."},{"key":"1118_CR49","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S1473-3099(17)30240-2","volume":"17","author":"P Pitisuttithum","year":"2017","unstructured":"Pitisuttithum, P. et al. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A\/17\/turkey\/Turkey\/05\/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial. Lancet Infect. Dis. 17, 833\u2013842 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"1118_CR50","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2011.01.004","volume":"412","author":"I Isakova-Sivak","year":"2011","unstructured":"Isakova-Sivak, I. et al. Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A\/Leningrad\/134\/17\/57 (H2N2). Virology 412, 297\u2013305 (2011).","journal-title":"Virology"},{"key":"1118_CR51","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2018.03.013","volume":"518","author":"I Isakova-Sivak","year":"2018","unstructured":"Isakova-Sivak, I. et al. Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin. Virology 518, 313\u2013323 (2018).","journal-title":"Virology"},{"key":"1118_CR52","doi-asserted-by":"crossref","first-page":"e0194830","DOI":"10.1371\/journal.pone.0194830","volume":"13","author":"M Rajendran","year":"2018","unstructured":"Rajendran, M. et al. An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations. PLoS ONE 13, e0194830 (2018).","journal-title":"PLoS ONE"},{"key":"1118_CR53","first-page":"2057","volume":"3","author":"L Mart\u00ednez-Sobrido","year":"2010","unstructured":"Mart\u00ednez-Sobrido, L. & Garc\u00eda-Sastre, A. Generation of recombinant influenza virus from plasmid DNA. J. Vis. Exp. 3, 2057 (2010).","journal-title":"J. Vis. Exp."},{"key":"1118_CR54","doi-asserted-by":"crossref","first-page":"12471","DOI":"10.1128\/JVI.01388-13","volume":"87","author":"M Hong","year":"2013","unstructured":"Hong, M. et al. Antibody recognition of the pandemic H1N1 influenza virus hemagglutinin receptor binding site. J. Virol. 87, 12471\u201312480 (2013).","journal-title":"J. Virol."},{"key":"1118_CR55","first-page":"e51112","volume":"6","author":"I Margine","year":"2013","unstructured":"Margine, I., Palese, P. & Krammer, F. Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system. J. Vis. Exp. 6, e51112 (2013).","journal-title":"J. Vis. Exp."},{"key":"1118_CR56","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1126\/science.aac7263","volume":"349","author":"A Impagliazzo","year":"2015","unstructured":"Impagliazzo, A. et al. A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen. Science 349, 1301\u20131306 (2015).","journal-title":"Science"},{"key":"1118_CR57","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.omtm.2019.12.003","volume":"16","author":"CM Bliss","year":"2020","unstructured":"Bliss, C. M. et al. Targeting antigen to the surface of EVs improves the in vivo immunogenicity of human and non-human adenoviral vaccines in mice. Mol. Ther. Methods Clin. Dev. 16, 108\u2013125 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"1118_CR58","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.aay0678","volume":"366","author":"D Stadlbauer","year":"2019","unstructured":"Stadlbauer, D. et al. Broadly protective human antibodies that target the active site of influenza virus neuraminidase. Science 366, 499\u2013504 (2019).","journal-title":"Science"},{"key":"1118_CR59","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1080\/22221751.2019.1637284","volume":"8","author":"G Wang","year":"2019","unstructured":"Wang, G. et al. Characterization of swine-origin H1N1 canine influenza viruses. Emerg. Microbes Infect. 8, 1017\u20131026 (2019).","journal-title":"Emerg. Microbes Infect."},{"key":"1118_CR60","doi-asserted-by":"crossref","first-page":"e0183315","DOI":"10.1371\/journal.pone.0183315","volume":"12","author":"V Chromikova","year":"2017","unstructured":"Chromikova, V., Zaragoza, M. A. & Krammer, F. Generation of a serum free CHO DG44 cell line stably producing a broadly protective anti-influenza virus monoclonal antibody. PLoS ONE 12, e0183315 (2017).","journal-title":"PLoS ONE"},{"key":"1118_CR61","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3389\/fimmu.2019.02005","volume":"10","author":"M McMahon","year":"2019","unstructured":"McMahon, M. et al. Vaccination with viral vectors expressing chimeric hemagglutinin, NP and M1 antigens protects ferrets against influenza virus challenge. Front. Immunol. 10, 2005 (2019).","journal-title":"Front. Immunol."},{"key":"1118_CR62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/ajg.2008.120","volume":"104","author":"Y Lu","year":"2009","unstructured":"Lu, Y. et al. Immune response to influenza vaccine in children with inflammatory bowel disease. Am. J. Gastroenterol. 104, 444\u2013453 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"1118_CR63","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1001\/jama.297.14.1577","volume":"297","author":"J Treanor","year":"2007","unstructured":"Treanor, J. et al. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. JAMA 297, 1577\u20131582 (2007).","journal-title":"JAMA"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1118-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1118-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T18:33:52Z","timestamp":1733942032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-020-1118-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1118"],"URL":"https:\/\/doi.org\/10.1038\/s41591-020-1118-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739166337.793584025","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,7]]},"assertion":[{"value":"3 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Icahn School of Medicine at Mount Sinai (ISMMS) has issued patents and filed patent applications covering the use of chimeric hemagglutinin antigens as vaccines. R.N., A.G.-S., P.P. and F.K. are named as inventors on these patents and applications. The ISMMS and the inventors have received payments as consideration for these rights. The laboratories of A.G.-S., P.P. and F.K. were also engaged in a research program that was funded by GlaxoSmithKline Biologicals SA. M.V.d.W. declares that she is employed by the GSK group of companies and declares no nonfinancial conflicts of interest. C. Claeys was an employee of the GSK group of companies at the time the study was performed. B.L.I. was an employee of the GSK group of companies until 2017 and held shares from this group of companies at the time the study was performed. He is also named as inventor on a patent family regarding influenza virus vaccine constructs filed by the ISMMS and the GSK group of companies. E.B.W. is a coinvestigator for a clinical trial supported by Pfizer. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}